Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lluch

Showing results (101-110 of 176) with videos related to

Pageof 18
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 27, 1997
Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) statusD Torregrosa, P Bolufer, A Lluch, et al.
Allergologia Et Immunopathologia|May 1, 1985
Mechanism of suppression of the depressed lymphocyte response in lung cancer patientsV Alberola, A González-Molina, A Trenor, et al.
European Journal of Cancer (Oxford, England : 1990)|February 13, 2001
Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissuesJ Torres, S Navarro, I Roglá, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Gemcitabine in combination with doxorubicin in advanced breast cancer: final results of a phase II pharmacokinetic trialG Pérez-Manga, A Lluch, E Alba, et al.
Seminars in Oncology|March 4, 2000
Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: preliminary results of a phase II trialR Colomer, A Llombart, A Lluch, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 28, 2006
The "El Alamo" project (1990-1997): two consecutive hospital-based studies of breast cancer outcomes in SpainM Martín, E Mahillo, A Llombart-Cussac, et al.
Bone Marrow Transplantation|June 1, 2002
The role of granulocyte colony-stimulating factor (G-CSF) in the post-transplant periodJ Hornedo, C Solá, C Solano, et al.
Medicina Clinica|October 10, 1987
[Estrogen and progesterone receptors in cancer of the breast]A Lluch, A Artero, A Cervantes, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 30, 2014
Subcutaneous trastuzumab: drug development and current positionP Martín Martorell, B Bermejo de Las Heras, J A Pérez-Fidalgo, et al.
Vaccine|August 19, 2014
Intradermal and virosomal influenza vaccines for preventing influenza hospitalization in the elderly during the 2011-2012 influenza season: a comparative effectiveness study using the Valencia health care information systemJ Puig-Barberà, A Natividad-Sancho, J Calabuig-Pérez, et al.
Pageof 18

Showing results (101-110 of 176) with videos related to

Sort By:
Pageof 18
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 27, 1997
Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) statusD Torregrosa, P Bolufer, A Lluch, et al.
Allergologia Et Immunopathologia|May 1, 1985
Mechanism of suppression of the depressed lymphocyte response in lung cancer patientsV Alberola, A González-Molina, A Trenor, et al.
European Journal of Cancer (Oxford, England : 1990)|February 13, 2001
Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissuesJ Torres, S Navarro, I Roglá, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Gemcitabine in combination with doxorubicin in advanced breast cancer: final results of a phase II pharmacokinetic trialG Pérez-Manga, A Lluch, E Alba, et al.
Seminars in Oncology|March 4, 2000
Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: preliminary results of a phase II trialR Colomer, A Llombart, A Lluch, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 28, 2006
The "El Alamo" project (1990-1997): two consecutive hospital-based studies of breast cancer outcomes in SpainM Martín, E Mahillo, A Llombart-Cussac, et al.
Bone Marrow Transplantation|June 1, 2002
The role of granulocyte colony-stimulating factor (G-CSF) in the post-transplant periodJ Hornedo, C Solá, C Solano, et al.
Medicina Clinica|October 10, 1987
[Estrogen and progesterone receptors in cancer of the breast]A Lluch, A Artero, A Cervantes, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 30, 2014
Subcutaneous trastuzumab: drug development and current positionP Martín Martorell, B Bermejo de Las Heras, J A Pérez-Fidalgo, et al.
Vaccine|August 19, 2014
Intradermal and virosomal influenza vaccines for preventing influenza hospitalization in the elderly during the 2011-2012 influenza season: a comparative effectiveness study using the Valencia health care information systemJ Puig-Barberà, A Natividad-Sancho, J Calabuig-Pérez, et al.
Pageof 18